Get the Stockscreener App
2.3748
8.55%
0.1871
Im Cannabis Corp stock is traded at $2.3748, with a volume of 17,167.
It is up +8.55% in the last 24 hours and up +14.17% over the past month.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
See More
Previous Close:
$2.1877
Open:
$2.18
24h Volume:
17,167
Relative Volume:
0.20
Market Cap:
$7.33M
Revenue:
$77.52M
Net Income/Loss:
$-52.14M
P/E Ratio:
-0.3665
EPS:
-6.479
Net Cash Flow:
$-8.37M
1W Performance:
+5.08%
1M Performance:
+14.17%
6M Performance:
+5.55%
1Y Performance:
+73.07%
1-Day Range:
$2.18
$2.455
1-Week Range:
$2.11
$2.5554
52-Week Range:
$1.134
$8.10
Im Cannabis Corp Stock (IMCC) Company Profile
Compare IMCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMCC
Im Cannabis Corp
|
2.3748 | 7.33M | 77.52M | -52.14M | -8.37M | -6.479 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Im Cannabis Corp Stock (IMCC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-05-21 | Initiated | ROTH Capital | Buy |
| Jul-14-21 | Initiated | Desjardins | Buy |
Im Cannabis Corp Stock (IMCC) Latest News
IM Cannabis Announces Change of Auditors - PR Newswire
IM Cannabis Corp. Announces Auditor Change to Enhance Financial Transparency - TipRanks
IM Cannabis Appoints Grant Thornton Israel as New Auditor, Replacing Ernst & Young Member Firm - StockTitan
IM Cannabis (NASDAQ:IMCC) Trading Down 6.6% – Time to Sell? - Defense World
Issue 382 | International Cannabis Weekly - Prohibition Partners
IM Cannabis Corp. Faces Global Challenges and Awaits Regulatory Reforms - TipRanks
IM Cannabis Corp Raises Funds Amid Global Challenges - TipRanks
Ironwood Pharmaceuticals (IRWD) Stock Surges Amid Strong Financials and Buy Ratings - GuruFocus.com
IM Cannabis Announces Receipt of Court Action - GuruFocus.com
IMC Germany Announces Outstanding Preliminary Q3, 2024 Performan - GuruFocus.com
IM Cannabis Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
This Cannabis Company Is Snapping Up America’s Craft Beer Brewers - The Wall Street Journal
IM Cannabis to Report Third Quarter 2024 Financial Results on Th - GuruFocus.com
IM Cannabis Reports Third Quarter Financial Results - mg Magazine
California Cannabis Company Lowell Farms Reports 48% YoY Revenue Decline In Q3 - Benzinga
IM Cannabis Corp (IMCC) Q3 2024 Earnings Call Highlights: Revenue Surge and Operational Efficiency Gains - GuruFocus.com
IM Cannabis Corp (IMCC) Q3 2024 Earnings Call Highlights: Revenue Surge and Operational ... - Yahoo Finance
IM Cannabis Posts Revenue Growth and Expense Cuts - TipRanks
Earnings call: IM Cannabis reports revenue growth amid operational challenges - Investing.com
IM Cannabis Closes Non-Brokered Private Placement led by Management - mg Magazine
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3 - Benzinga
IM Cannabis reports increase in German revenue, but decrease in Israeli - Green Market Report
IM Cannabis Reports Revenue Growth and Efficiency Gains - TipRanks
Finansavisen - Finansavisen
Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding - Business of Cannabis -
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement - Lelezard
Veterans targeted by medicinal cannabis businesses on social media spruiking free products and subscriptions - ABC News
IM Cannabis Corp expected to post a loss of C$1.41 a shareEarnings Preview - XM
IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET - KelownaNow
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?Auxly Cannabis Group (OTC:CBWTF), Canopy Gwth (NASDAQ:CGC) - Benzinga
IM Cannabis to Announce Q3 2024 Financial Results - TipRanks
IM Cannabis Corp: Revenue Surge and Expansion Plans - TipRanks
IMC applauds the April 1st implementation of the new Israeli can - GuruFocus.com
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis - GuruFocus.com
IM Cannabis Announces Appointment of Shmulik Arbel to Board of D - GuruFocus.com
IM Cannabis Reports Second Quarter Financial Results - GuruFocus.com
IM Cannabis Closes Convertible Debenture Offering to Support Acc - GuruFocus.com
Global Growth Boosts Organigram’s Strategic Expansion Plans - The Dales Report
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management - Barchart
How Cannabis Legalization in Germany Boosted IM Cannabis’ Revenue: Will Spain’s Medical Marijuana Framework Do the Same? | Home - 420 Intel
IM Cannabis announces $1.6 million private placement to repay loan - Marijuana Business Daily
IM Cannabis Corp (IMCC) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges - GuruFocus.com
IM Cannabis announces private placement offering - Investing.com
IM Cannabis announces private placement offering By Investing.com - Investing.com South Africa
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know - Benzinga
IM Cannabis plans $1.6M private placement, reshuffles options - Green Market Report
IM Cannabis Corp. Plans Private Placement and Restructures Incentives - TipRanks
IM Cannabis Corp. announced that it expects to receive $1.613 million in funding - Marketscreener.com
How Cannabis Legalization in Germany Boosted IM Cannabis’ Revenue: Will Spain’s Medical Marijuana Framework Do the Same? - TimesOfCannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same? - Benzinga
Im Cannabis Corp Stock (IMCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):